# Ablative Radioembolization of Renal Cell Carcinoma Trial

> **NCT06642220** · PHASE2 · RECRUITING · sponsor: **Derek W. Cool** · enrollment: 16 (estimated)

## Conditions studied

- Renal Cell Carcinoma (RCC)
- Radioembolization

## Interventions

- **DEVICE:** Y-90 Selective Internal Radiation Therapy (SIRT)

## Key facts

- **NCT ID:** NCT06642220
- **Lead sponsor:** Derek W. Cool
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-09
- **Primary completion:** 2028-12
- **Final completion:** 2032-12-31
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642220, "Ablative Radioembolization of Renal Cell Carcinoma Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06642220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*